7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Brain & Nerves

Movement Disorders Treatment: How Tremor, Dystonia and Parkinsonism Are Managed Differently

25 min read
Movement Disorders Treatment: How Tremor, Dystonia and Parkinsonism Are Managed Differently

Key Takeaways

  • Tremor that appears during action, without slowness, is usually essential tremor rather than Parkinson's, and the two are treated with entirely different medicine classes.
  • The NHS estimates Parkinson's disease affects around 1 in 500 people, with about 1 in 20 of those first noticing symptoms before the age of 40.
  • Botulinum toxin injections are the first-line treatment for focal dystonia, with effect building over one to two weeks and typically repeated about every three months.
  • Painful early-morning toe or foot cramping in Parkinson's is usually dystonia linked to low overnight dopamine levels, and a timing diary is the most useful thing to bring to the neurologist.
  • Hemichorea most often follows a small basal ganglia stroke or very high blood sugar, and correcting the glucose alone can settle the movements over days to weeks.
  • Deep brain stimulation is usually considered when medicines still work but have become unreliable, and is less likely to help when the diagnosis is uncertain or thinking and balance are the main problems.
Quick Answer

Movement disorders are treated according to the circuit that is misfiring, not the symptom alone. Essential tremor is usually managed with beta blockers or anti-seizure medicines and, for severe cases, focused ultrasound or deep brain stimulation. Dystonia often responds best to botulinum toxin injections and physical therapy. Parkinsonism is treated by replacing or protecting dopamine, with the precise plan decided by a neurologist.

A retired teacher notices her coffee cup trembling only when she lifts it. Her neighbor’s hand shakes while it rests in his lap and goes quiet the moment he reaches for the remote. A third person has a foot that curls inward on morning walks and will not straighten until he stops. All three have been told, at some point, “it’s probably Parkinson’s.” Only one of them is likely to be right.

That is the first thing to understand about how movement disorders are treated: the label comes before the medicine, and the label depends on details that are easy to miss in a short appointment. Tremor at rest and tremor in action point to different brain circuits. A twisting posture is not a shake. Chorea, the restless, dance-like flow of movement, is a separate problem again.

This explainer walks through what neurologists actually do for tremor, dystonia and parkinsonism, why the plans diverge, and what the following weeks tend to look like once treatment begins.

How movement disorders are treated: the label decides the plan

A movement disorder is a neurological condition that causes either too much movement (tremor, chorea, tics, dystonia) or too little (the slowness and stiffness of parkinsonism). MedlinePlus groups dozens of conditions under this heading, which is exactly why the first clinic visit is spent watching rather than prescribing. The neurologist asks you to hold your arms out, pour water, write a sentence, walk down a corridor and turn. Each task provokes a different circuit.

Three distinctions carry most of the weight. First, does the movement happen at rest or with action? A hand that shakes while relaxed in the lap suggests parkinsonism; a hand that shakes when reaching for a glass suggests essential tremor. Second, is the movement rhythmic or sustained? A rhythmic oscillation is tremor; a prolonged twisting pull is dystonia. Third, is anything slow? Slowness of movement, called bradykinesia, is the defining feature of parkinsonism, and its absence makes a Parkinson’s diagnosis unlikely regardless of how much shaking there is.

From those answers the treatment paths separate quickly. Essential tremor is usually managed with medicines that dampen the oscillation, with procedures reserved for severe cases. Dystonia is most often treated locally, with injections that quiet overactive muscles. Parkinsonism is treated by addressing the dopamine shortage that underlies it, and when the cause is a medicine or a vascular problem, by addressing that instead.

Diagnosis is clinical in most cases. Scans are used to exclude structural causes or, in specific situations, to help separate parkinsonism from tremor. Blood tests can identify thyroid problems, copper disorders or metabolic triggers that produce movement disorders of their own. A working diagnosis may be revised as the pattern evolves, and good clinicians say so plainly rather than pretending certainty.

What actually happens inside the brain when treatment works

Most movement disorders arise in a set of deep structures called the basal ganglia, which act like a volume control for movement, and in the cerebellum, which handles timing and coordination. Treatment works by nudging one of three levers: a chemical messenger, a muscle, or an electrical circuit.

Elderly patient eating vegetables with doctor observing: What actually happens inside the brain when treatment works

The chemical lever matters most in parkinsonism. Nerve cells that make dopamine, a messenger that lets the basal ganglia release planned movements, gradually fail. Medicines either supply the raw material the brain converts into dopamine, mimic dopamine at its receptors, or slow the enzymes that break it down. Chorea is in some ways the mirror image: an overactive dopamine signal, which is why the medicines used for chorea block or deplete dopamine rather than boost it.

The muscle lever is the mainstay for dystonia. Botulinum toxin, a purified protein injected in tiny amounts, blocks the signal from nerve to muscle at the injection site. The brain is still sending the wrong instruction; the muscle simply cannot answer it fully. The effect is local, temporary, and repeatable, which is why it suits a problem confined to the neck, eyelids, hand or voice.

The electrical lever is deep brain stimulation, a surgical treatment in which fine electrodes placed in a precise target deliver continuous pulses from a device under the skin. The pulses do not destroy tissue; they interrupt the abnormal rhythm that drives tremor or dystonic pull. Focused ultrasound takes the opposite approach, using converging sound waves to create a small, deliberate lesion in a tremor circuit without an incision.

Underneath all three sits rehabilitation. Physical, occupational and speech therapists retrain movement patterns, protect balance and preserve independence, and no medicine or device replaces that work.

Essential tremor treatment options: why a shaky hand is usually not Parkinson's

Essential tremor is a rhythmic shaking that appears during action, typically in the hands, sometimes in the head or voice. It is the most common tremor disorder, often runs in families, and tends to worsen slowly over years. Mayo Clinic notes that stress, fatigue, caffeine and temperature extremes can make it more noticeable, which explains why the same hand can be steady at breakfast and unsteady after three coffees and a difficult meeting.

Treatment starts with asking how much the tremor interferes. Many people need nothing beyond reassurance and practical adjustments: a heavier mug, a wide-grip pen, drinking from a cup that is half full. When tremor spills coffee, makes signatures unreadable or stops someone eating in public, medicines come in.

Two classes carry most of the evidence. Beta blockers, medicines originally developed for blood pressure, reduce the amplitude of the shake in many people. Certain anti-seizure medicines are the main alternative or add-on. Neither works for everyone, and both bring side effects the prescriber weighs against benefit; people with asthma or very slow heart rates, for instance, may not be offered a beta blocker. For head or voice tremor, botulinum toxin injections are sometimes used, accepting a trade-off of temporary weakness in the treated muscles.

When medicines fail and the tremor is disabling, two procedures are considered. Deep brain stimulation targets the thalamus, a relay station that passes tremor rhythm to the cortex. Focused ultrasound thalamotomy creates a tiny lesion in the same region, usually on one side. Mayo Clinic lists both as options for severe, medicine-resistant tremor. Which, if either, suits a given person depends on age, other health conditions, whether both hands are affected, and personal priorities, all of which the treating team works through.

What is muscle dystonia, and how is it managed?

Dystonia is a condition in which muscles contract involuntarily and for too long, producing twisting movements, repetitive motions or abnormal postures. The National Institute of Neurological Disorders and Stroke describes it as a disorder of the brain’s movement control rather than of the muscle itself, even though the muscle is where you feel it. It can affect one area (a neck that pulls to one side, eyelids that clamp shut, a hand that cramps only when writing), several adjacent areas, or the whole body.

Doctor consulting patient about arm or joint problem: What is muscle dystonia, and how is it managed?

Where it started tells the clinician a lot. Dystonia beginning in childhood, often in a leg, is more likely to spread and to have a genetic basis, so genetic testing may be offered. Dystonia beginning in adulthood usually stays focal, meaning confined to one region. Some dystonia follows a brain injury, stroke, or prolonged use of certain medicines, and in those cases the trigger shapes the plan.

For focal dystonia, botulinum toxin injections are the first-line treatment in most guidelines. The clinician identifies which muscles are pulling, sometimes with electromyography (a fine needle that records muscle electrical activity), then injects those muscles. NHS guidance notes the effect wears off, so injections are usually repeated about every three months. Timing, muscle selection and amount are adjusted at each visit based on what the previous round did.

Oral medicines play a supporting role, particularly in generalized dystonia. One group, which raises a calming brain messenger, and another, which reduces acetylcholine signalling, are used in specific situations. A small subset of childhood-onset dystonia responds strikingly to the same raw material used for Parkinson’s, which is why children with unexplained dystonia are often given a trial. Physical therapy, sensory tricks such as touching the chin to settle neck dystonia, and for severe cases deep brain stimulation complete the toolkit.

Parkinsonism vs Parkinson's disease: why the distinction changes treatment

Parkinsonism is the umbrella term for the combination of slowness, stiffness, rest tremor and balance trouble. Parkinson’s disease is the most common cause, but not the only one, and the difference matters because the other causes respond differently to treatment.

Parkinson’s disease itself is a gradual loss of dopamine-producing cells. The NHS estimates it affects around 1 in 500 people, with most noticing symptoms after 50, though around 1 in 20 first experience symptoms before 40. It typically begins on one side, responds well to dopamine replacement, and progresses over years.

Drug-induced parkinsonism looks similar but is caused by medicines that block dopamine receptors, most often certain antipsychotics and some anti-nausea drugs. Here the treatment is not to add dopamine but to review the offending medicine with the prescriber, a change that is never made by the patient alone and may take months to show full effect.

Vascular parkinsonism follows multiple small strokes in the basal ganglia. It tends to affect the legs more than the arms, producing a shuffling walk with relatively steady hands, and responds less reliably to dopamine medicines; management leans toward stroke prevention and gait rehabilitation.

Then there are the so-called atypical parkinsonian disorders, including multiple system atrophy and progressive supranuclear palsy. These share the slowness but add features such as early falls, eye-movement problems or blood pressure that drops on standing. Dopamine medicines may help modestly or briefly, and the care plan shifts earlier toward therapy, safety and symptom control.

Separating these is not always possible at the first visit. A neurologist will often start treatment for the most likely diagnosis and revisit the label if the response or the pattern over the following year does not fit.

How Parkinson's disease medicines are used over time

The core of Parkinson’s treatment is restoring dopamine signalling, and three classes do this in different ways. Levodopa is converted into dopamine inside the brain; it is the most effective symptom treatment and, according to the NHS, most people with Parkinson’s eventually need it. Dopamine agonists mimic dopamine at its receptors without needing conversion. MAO-B inhibitors slow the enzyme that breaks dopamine down, stretching the supply that remains. All three are taken on a schedule that the neurologist sets and adjusts.

Which comes first depends on age, symptom severity, work demands and side-effect risk. Younger people are sometimes started on an agonist or MAO-B inhibitor to delay levodopa, because long-term levodopa use is associated with complications. Older people, or anyone whose symptoms are already affecting function, are often started on levodopa because it works more reliably. Neither approach is right for everyone, and the trade-offs are explained rather than imposed.

Two complications shape the middle years. Wearing-off describes a dose losing effect before the next is due, so that movement becomes stiff and slow in the gap. Dyskinesia, the involuntary writhing movements that appear when levels peak, is the opposite problem. Clinicians manage both by changing timing, adding medicines that smooth the levels, or in advanced disease, using continuous delivery methods or deep brain stimulation.

Side effects are tracked at every visit. Nausea, dizziness on standing and drowsiness are common early on. Dopamine agonists in particular can trigger impulse control problems such as compulsive gambling, shopping or eating, which the NHS flags as something families should watch for and report.

Nothing in this section is a prescription. Starting, stopping or changing any of these medicines without the treating team is unsafe, because abrupt withdrawal can cause serious worsening.

Are muscle cramps a common symptom of Parkinson's disease?

Yes. Painful muscle cramping is commonly reported in Parkinson’s disease and often appears before anyone connects it to the diagnosis. The typical story is a toe that curls under, a foot that turns inward, or a calf that knots up in the early morning before the first dose of the day has taken effect. This is usually dystonia rather than an ordinary cramp, and the distinction changes what helps.

In Parkinson’s, dystonia tends to track dopamine levels. Early-morning dystonia happens when overnight levels are lowest. Wearing-off dystonia appears in the gap between doses. Peak-dose dystonia, less common, shows up when levels are highest. Because the timing is the clue, a symptom diary noting when cramps occur relative to medication times gives the neurologist far more to work with than the word “cramps” alone.

Management follows from the cause. When cramping clusters around low points, the prescriber may adjust the timing or formulation of dopamine medicines. When a specific muscle group is reliably involved, botulinum toxin can be injected locally, the same approach used for primary dystonia. Stretching, warm compresses and physical therapy help many people, and are safe to use alongside whatever medicines are prescribed.

Not every cramp in a person with Parkinson’s is Parkinson’s. Low magnesium or potassium, dehydration, thyroid problems, peripheral nerve disease and some medicines unrelated to Parkinson’s all cause cramps, and a simple blood panel rules most of them out. Pain that is constant rather than episodic, cramps with swelling or redness of a single calf, or muscle weakness that is new and progressive deserve separate evaluation rather than being filed under the existing diagnosis. The treating team decides which investigations, if any, are needed.

What is chorea syndrome, and how is hemichorea treated?

Chorea is a pattern of involuntary, irregular, flowing movements that seem to drift unpredictably from one body part to another, as if the person were restless or fidgeting. The word comes from the Greek for dance. “Chorea syndrome” is not one disease but a description of this movement pattern plus whatever is causing it, and the cause is the whole story when it comes to treatment.

Huntington’s disease is the best-known genetic cause. The NHS notes that symptoms usually begin between 30 and 50, and that each child of an affected parent has a 50 percent chance of inheriting the altered gene. Treatment cannot alter the course, but medicines that block or deplete dopamine, a class called VMAT2 inhibitors among them, can reduce the chorea, and a multidisciplinary team manages the mood, cognitive and swallowing problems that accompany it.

Sydenham chorea follows a streptococcal throat infection, mostly in children, and is treated by addressing the infection, protecting the heart, and in some cases using short-term medicines for the movements while they settle. Chorea can also be triggered by pregnancy, thyroid disease, lupus, certain medicines including long-term levodopa, and stroke.

Hemichorea means chorea confined to one side of the body. The two most common causes are a small stroke in the basal ganglia on the opposite side, and very high blood sugar in people with uncontrolled diabetes, a syndrome sometimes called hyperglycemic hemichorea. The second is a genuinely satisfying situation for a neurologist: correcting the glucose often settles the movements over days to weeks, and dopamine-blocking medicines are used only as a bridge if needed. Post-stroke hemichorea is managed with the same dopamine-modulating medicines, alongside the usual stroke prevention measures. A scan and blood sugar check are therefore the first steps for anyone with new one-sided chorea.

Deep brain stimulation for tremor, dystonia and Parkinson's: who it is usually for, and who is asked to wait

Deep brain stimulation is the procedure patients ask about most, and the one with the strictest selection. It is usually offered when a well-established diagnosis has responded to medicine but the medicine can no longer deliver a stable result, whether because of tremor that breaks through, dystonia that injections cannot reach, or Parkinson’s with disabling wearing-off and dyskinesia. The NHS is clear that it is not suitable for everyone.

The target depends on the disorder. For essential tremor, electrodes go to the thalamus. For Parkinson’s, the usual targets are the subthalamic nucleus or the globus pallidus, structures within the basal ganglia. For dystonia, the globus pallidus is the typical choice. The electrodes connect to a pulse generator placed under the skin of the chest, and settings are programmed and refined over multiple visits.

Who is typically asked to wait, or not offered the procedure at all? People whose diagnosis is still uncertain, because atypical parkinsonism tends to respond poorly. People whose main problems are ones stimulation does not address: in Parkinson’s, that means thinking and memory changes, speech difficulty, or balance and freezing that persist even when medicine is working. People with significant untreated depression or anxiety, which the assessment screens for because the procedure and the adjustment period are demanding. People with other medical conditions that raise surgical risk.

Risks are those of any brain surgery, chiefly bleeding and infection, plus device-related issues such as lead movement or hardware failure, and stimulation side effects like speech change or tingling that programming can usually adjust. The assessment typically involves a neurologist, neurosurgeon, neuropsychologist and specialist nurse. The team’s conclusion, not the strength of a patient’s wish, decides whether to proceed.

Tremor, dystonia, parkinsonism and chorea compared

Seeing the four main patterns side by side makes the logic of treatment clearer. Each row is a generalization; individual plans are always narrower than this.

Pattern What it looks like Usual underlying problem First-line approach Procedures considered if needed
Essential tremor Rhythmic shaking during action, hands, head or voice Over-active cerebellar-thalamic rhythm, often familial Beta blocker or anti-seizure medicine; practical aids Thalamic deep brain stimulation; focused ultrasound
Dystonia Sustained twisting, abnormal posture, task-specific cramp Faulty basal ganglia control of muscle tone Botulinum toxin injections; physical therapy; oral medicines for generalized forms Pallidal deep brain stimulation
Parkinsonism Slowness, stiffness, rest tremor, small steps Dopamine shortage (Parkinson’s) or receptor blockade, vascular damage, atypical degeneration Dopamine replacement; medicine review if drug-induced; therapy Subthalamic or pallidal deep brain stimulation; continuous drug delivery
Chorea Irregular, flowing, unpredictable movements Excess dopamine signalling; genetic, metabolic, immune or vascular triggers Treat the cause; dopamine-blocking or depleting medicine for symptoms Rarely surgical; supportive and multidisciplinary care

Two features cut across every row. The first is that rehabilitation therapists are involved from the start, not held in reserve for when medicines fail. The second is that the cause, where one can be found, is always treated ahead of the symptom. A tremor from an overactive thyroid, a dystonia from a dopamine-blocking anti-nausea medicine, or a hemichorea from high blood sugar may settle without any neurological medicine at all once the trigger is corrected.

Overlap is common. Many people with Parkinson’s also have dystonia; some people with long-standing essential tremor develop parkinsonian features; chorea can emerge as a side effect of treating Parkinson’s. Clinicians treat the combination they see rather than forcing a person into one box.

What the following days and weeks usually look like after starting treatment

Timelines differ sharply across the three groups, and knowing the expected pace prevents both premature disappointment and false reassurance.

Dopamine replacement for Parkinson’s often produces noticeable improvement within days, and the NHS describes a clear response as one of the features that supports the diagnosis. Even so, the prescriber usually waits several weeks before judging a given regimen, because nausea and dizziness in the first days often fade, and because the aim is a stable response across the whole day rather than a good hour. Expect a follow-up visit, a review of a symptom diary, and small adjustments rather than one large one.

Botulinum toxin for dystonia follows a different curve. Little happens in the first few days. Effect builds over about one to two weeks, holds for a period, then fades, with NHS guidance putting the typical cycle at around three months before repeat injections. The first round is partly a mapping exercise; the second is usually more precise.

Tremor medicines are typically increased stepwise by the prescriber, so the full effect may take several weeks to assess. Some people notice benefit quickly; others find the side effects arrive before the benefit and need a different class.

After deep brain stimulation, the device is often switched on days to weeks after implantation once swelling settles, and programming sessions continue for months. Tremor and Parkinson’s symptoms can respond within sessions; dystonia characteristically improves slowly, sometimes over many months, which is why early programming visits may feel underwhelming.

Across all of these, the rhythm is the same: a trial period, an honest review, and adjustment. People who keep a simple log of symptoms, timing and side effects consistently get more out of each appointment than those relying on memory.

Physical therapy, exercise and daily life: the treatment that is never optional

Ask a movement disorder specialist what they would keep if they could keep only one intervention for Parkinson’s and most will say exercise. The NHS lists physiotherapy, occupational therapy and speech and language therapy as core parts of Parkinson’s care rather than add-ons, and the same holds, with different emphasis, for dystonia and tremor.

For parkinsonism, the goal is to counter the shrinkage of movement that the disease imposes. Physical therapists teach large, deliberate steps, cueing strategies for freezing (counting, a line on the floor, a metronome), and techniques for turning and rising from a chair. Aerobic exercise, strength work and balance training each address a different deficit. Speech therapists work on volume and swallowing, both of which fade quietly and both of which carry real risk if ignored.

For dystonia, therapy aims to retrain posture and reduce the compensations that build up around the pull. Sensory tricks, called gestes antagonistes, are a real phenomenon: a light touch to the chin or the back of the head can momentarily release neck dystonia, and therapists help people find and use their own. In task-specific dystonia such as writer’s cramp, changing grip, pen or writing angle can matter as much as any injection.

For tremor, occupational therapists supply weighted utensils, non-slip mats and adaptive strategies that reduce the daily friction without touching the underlying rhythm. Reducing caffeine, managing sleep and finding ways to lower stress all have an effect that Mayo Clinic acknowledges and that patients often underestimate.

Mental health belongs here too. Depression and anxiety are common across movement disorders, worsen motor symptoms, and are treatable. Raising them with the team is part of treatment, not a separate matter.

What people often get wrong about movement disorder treatment

“Shaking means Parkinson’s.” Most tremor is not Parkinson’s. Essential tremor is more common, and action tremor without slowness points away from parkinsonism. Getting this wrong leads to dopamine medicines that cannot help and side effects without benefit.

“Levodopa should be delayed as long as possible because it stops working.” The medicine does not wear out. The disease progresses, and the brain’s ability to store and smooth dopamine declines, which produces wearing-off and dyskinesia. Modern guidance, reflected in NHS advice, treats the timing of levodopa as an individual decision balancing current function against future complications, not a race to be postponed at any cost.

“Botulinum toxin is a cosmetic treatment.” It was used for neurological conditions before it was ever used for wrinkles, and remains the first-line treatment for focal dystonia in mainstream guidelines.

“Deep brain stimulation is a last resort for people with nothing left.” It works best in people whose medicines still work but have become unreliable, and whose diagnosis is secure. Waiting until function has collapsed tends to produce poorer outcomes, which is why the assessment focuses on the right window rather than the latest possible moment.

“Supplements can replace prescribed treatment.” No supplement has been shown in reliable trials to treat tremor, dystonia or parkinsonism. Some interact with prescribed medicines, including high-protein products and certain amino acids that compete with levodopa absorption. Anything taken alongside treatment should be declared to the prescriber.

“If it’s a movement disorder, it must be degenerative.” Drug-induced parkinsonism, metabolic hemichorea, Sydenham chorea and functional movement disorders, in which the brain’s control of movement is disrupted without structural damage, can all improve substantially with the right approach. The label is a starting point, not a verdict.

Questions to ask your care team about how movement disorders are treated

Appointments are short and the questions are large. These are the ones that tend to change decisions, so they are worth bringing written down.

  • What is my working diagnosis, how confident are you in it, and what would make you reconsider?
  • Is this tremor, dystonia, parkinsonism or chorea, and does anything about my case suggest overlap?
  • Could any medicine I take for another condition be causing or worsening this, and who should review it?
  • What is the goal of the treatment you are proposing: less shaking, better walking, less pain, more reliable function during the day?
  • How will we know whether it is working, and roughly when should we expect to judge it?
  • What side effects should I watch for, and which ones mean I should call before my next appointment?
  • If this medicine does not suit me, what is the usual next step?
  • Would physical, occupational or speech therapy help me now, and how do I get referred?
  • Am I a candidate for botulinum toxin injections, focused ultrasound or deep brain stimulation, now or in the future, and what would need to be true?
  • Is there anything about driving, work or safety at home that I should change?
  • Should my family be involved in monitoring anything, such as mood changes or impulsive behavior?
  • Is genetic testing relevant for me or my relatives?

A good care team welcomes these questions and answers most of them unprompted. Where the answer is “we do not know yet,” that is not evasion; movement disorders are often diagnosed by watching how they change, and an honest clinician will say which of your questions can only be answered over time. Bringing a companion to take notes, and asking for a written summary of the plan, both reliably improve what you carry home.

When to call your doctor: red-flag signs that should not wait

Most changes in a movement disorder are gradual and belong in the next scheduled visit. A smaller set should prompt a same-day call, and a few mean emergency care.

Call emergency services or go to an emergency department if any abnormal movement, weakness or numbness begins suddenly on one side of the body, particularly with facial drooping, slurred speech, confusion or a severe headache. New one-sided chorea or sudden hemiballism (large flinging movements of one arm or leg) can signal a stroke or dangerously high blood sugar and is treated as an emergency until proven otherwise.

Seek urgent care the same day if someone with Parkinson’s becomes abruptly much stiffer, feverish, confused or unable to swallow, especially after a missed dose, a gastrointestinal illness or a medicine change. This combination can indicate a rare but serious reaction to disrupted dopamine treatment. The same applies to a high fever with rigidity in anyone taking dopamine-blocking medicines.

Contact the treating team promptly, within a day or two, for: a fall with injury or any new pattern of falling; choking on food or liquids, or a wet-sounding voice after swallowing; hallucinations, new confusion or sudden sleepiness during the day; new or worsening depression, or any thoughts of self-harm; impulsive behavior such as unexplained spending, gambling or eating, which can be a medicine effect; a dystonic spasm that will not release, or difficulty breathing after neck or throat injections; redness, swelling, fluid or fever near a deep brain stimulation device, or a sudden return of symptoms that suggests the device has stopped.

Never stop a prescribed movement disorder medicine on your own, even if you suspect it is causing a problem. Abrupt withdrawal of dopamine medicines can be dangerous. Describe the concern, and let the treating team decide what to adjust and how quickly.

Frequently asked questions

Are muscle cramps a common symptom of Parkinson's disease?

Yes, painful cramping is common in Parkinson’s and is usually dystonia, a sustained involuntary contraction, rather than an ordinary cramp. It often affects the toes, foot or calf early in the morning or between doses when dopamine levels are lowest. Treatment depends on timing: the prescriber may adjust medicine schedules, use botulinum toxin for a specific muscle, and recommend stretching and physical therapy. Cramps with swelling, redness or new weakness need separate assessment.

How is hemichorea treated?

Hemichorea, chorea on one side of the body, is treated by finding and correcting the cause first. The two most common causes are a small stroke in the opposite basal ganglia and very high blood sugar. In the diabetic form, bringing glucose under control often settles the movements over days to weeks. Dopamine-blocking or dopamine-depleting medicines may be used to reduce the movements in the meantime, with the treating neurologist deciding whether and for how long.

What is chorea syndrome?

Chorea syndrome describes a pattern of irregular, flowing, unpredictable involuntary movements together with whatever is causing them. Causes include Huntington’s disease, Sydenham chorea after a streptococcal infection, thyroid disease, pregnancy, lupus, certain medicines including long-term levodopa, stroke and very high blood sugar. Because the movements look similar across causes, blood tests, a medication review and often brain imaging are used to identify the trigger, and treatment is directed at that trigger before symptom-reducing medicines are considered.

What is muscle dystonia?

Muscle dystonia is a neurological condition in which muscles contract involuntarily and for too long, producing twisting movements, repetitive motions or abnormal postures. The fault lies in the brain’s movement control rather than the muscle itself. It can be focal, affecting one region such as the neck, eyelids or hand, or generalized. Focal dystonia is usually treated with botulinum toxin injections and physical therapy; generalized forms may need oral medicines and, in some cases, deep brain stimulation.

What are the main essential tremor treatment options?

Essential tremor is usually managed first with practical adjustments, then with beta blockers or certain anti-seizure medicines if the shaking interferes with eating, writing or work. Botulinum toxin is sometimes used for head or voice tremor. For severe, medicine-resistant tremor, deep brain stimulation of the thalamus or focused ultrasound thalamotomy are considered. Caffeine, stress, fatigue and temperature extremes can worsen tremor, so lifestyle review is part of the plan. The neurologist decides which option fits.

What is the difference between parkinsonism vs Parkinson's disease?

Parkinsonism is the umbrella term for slowness, stiffness, rest tremor and balance problems; Parkinson’s disease is its most common cause but not the only one. Drug-induced parkinsonism comes from dopamine-blocking medicines and is managed by reviewing those medicines with the prescriber. Vascular parkinsonism follows small strokes. Atypical parkinsonian disorders add features such as early falls or eye-movement problems and respond less to dopamine medicines. The distinction shapes which treatments are likely to help.

How does deep brain stimulation for tremor work?

Deep brain stimulation places fine electrodes in the thalamus, a relay station that passes tremor rhythm to the movement cortex, connected to a pulse generator under the skin of the chest. Continuous electrical pulses interrupt the abnormal rhythm without destroying tissue, and settings are programmed over several visits. It is considered for severe essential tremor that medicines cannot control, after a multidisciplinary assessment of diagnosis, general health and surgical risk. The team’s assessment determines suitability.

How long does botulinum toxin take to work for dystonia?

Little usually happens in the first few days. The effect builds over about one to two weeks, holds for a period, and then fades, with NHS guidance describing a typical cycle of around three months before injections are repeated. The first round is partly a mapping exercise to confirm which muscles are responsible, so the second is often more precise. Temporary weakness in the injected muscles is the main side effect, and the injector adjusts the plan at each visit.

Can a movement disorder be caused by medication?

Yes. Dopamine-blocking medicines, including certain antipsychotics and some anti-nausea drugs, can cause parkinsonism, dystonia, restlessness and, with long-term use, a persistent involuntary movement pattern called tardive dyskinesia. Some other medicine classes can worsen tremor. Management is a review of the responsible medicine with the prescriber, who weighs the reason it was started against the movement problem. People should never stop a prescribed medicine on their own, as abrupt withdrawal can be dangerous.

What is a functional movement disorder, and is it treatable?

A functional movement disorder is one in which the brain’s control of movement is disrupted without structural damage or a degenerative disease; the movements are real and involuntary, not imagined. It is diagnosed by positive clinical features, such as movements that change with distraction, rather than by excluding everything else. Treatment centers on explanation, specialist physiotherapy that retrains normal movement patterns, and psychological support where helpful. Many people improve substantially with the right approach.

References

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.

Dr. Şule Eren
Dr. Şule Eren, MD
Author
View profile →
Published November 22, 2026
Keep Reading

More from the Blog

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.